Natco Pharma on Wednesday, August 20, announced it has launched oral suspension tablets used in the treatment of pulmonary arterial hypertension (PAH).In an exchange...
Natco Pharma Ltd. on Wednesday, July 23, announced the acquisition of a 35.75% stake in South Africa-based Adcock Ingram Holdings Ltd., confirming a CNBC...